v3.26.1
Strategic Agreements - Additional Information (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2018
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Derivative liabilities - royalty agreement   $ 2,271   $ 2,271   $ 2,041
Ligand Development Funding Agreement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Payments totalling to fund development $ 15,000          
Maximum payments to receive upon achievement of milestones $ 8,000          
Agreement royalty term period from first sale 15 years          
Agreement termination notice period 90 days          
Aggregate potential future milestone payments remaining under arrangement   5,000   5,000    
Derivative liabilities - royalty agreement   2,300   2,300   2,000
Long-term liability   22,100   $ 22,100   $ 17,800
Effective interest rate percentage of potential future royalty payments       45.10%   44.90%
Non-cash interest expense   $ 2,300 $ 1,400 $ 4,300 $ 2,600  
Ligand Development Funding Agreement [Member] | Maximum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Royalty percentage 9.80%          
Ligand Development Funding Agreement [Member] | Minimum            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Royalty percentage 8.00%